Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy

Oral Oncology

Volumn 49, Issue 4, 2013, Pages 322-325

  Virós, David ^a   Camacho, Mercedes ^b   Zarraonandia, Iñaki ^c   García, Jacinto ^c   Quer, Miquel ^c   Vila, Luis ^b   León, Xavier ^c,d  

^a Hospitalet   (Spain)

^b BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Head and neck carcinoma; Metalloproteinase 2; Metalloproteinase 9; Metalloproteinases; Prognosis; Radiosensitivity

Indexed keywords

CISPLATIN; GELATINASE A; GELATINASE B; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84875257114     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.10.005     Document Type: Article

References (24)

1. P. Silva, N.J. Slevin, P. Sloan, H. Valentine, J. Cresswell, and D. Ryder Prognostic significance of tumor hypoxia inducible factor-1 alpha expression for outcome after radiotherapy in oropharyngeal cancer Int J Radiat Oncol Biol Phys 72 5 2008 1551 1559
2. E.I. Cho, D.P. Kowalski, C.T. Sasaki, and B.G. Haffty Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy Laryngoscope 114 11 2004 2001 2008
3. S.M. Bentzen, B.M. Atasoy, F.M. Daley, S. Dische, P.I. Richman, and M.I. Saunders Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 24 2005 5560 5567
4. K. Yoshida, R. Sasaki, H. Nishimura, Y. Okamoto, Y. Suzuki, and T. Kawabe Nuclear factor-κB expression as a novel marker of radioresistance in early-stage laryngeal cancer Head Neck 32 5 2010 646 655
5. M.A. Pavón, M. Parreño, X. León, F.J. Sancho, M.V. Céspedes, and I. Casanova Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer Int J Cancer 123 5 2008 1068 1079
6. E.L. Rosenthal, and L.M. Matrisian Matrix metalloproteases in head and neck cancer Head Neck 28 7 2006 639 648
7. P. O-charoenrat, P.H. Rhys-Evans, and S.A. Eccles Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 127 7 2001 813 820
8. A. Stokes, J. Joutsa, R. Ala-aho, M. Pitchers, C.J. Pennington, and C. Martin Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma Clin Cancer Res 16 7 2010 2022 2035
9. M. Xie, Y. Sun, and Y. Li Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implications for estimating lymph node mestastases Laryngoscope 114 12 2004 2243 2248
10. O.S. Bindhu, K. Ramadas, P. Sebastian, and M.R. Pillai High expression levels of nuclear factor kappa B and gelatinases in the tumorogenesis of oral squamous cell carcinoma Head Neck 28 10 2006 916 925
11. I. Yüce, A. Bayram, S. Caǧli, O. Canöz, S. Bayram, and E. Güney The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma Am J Otolaryngol 32 2 2011 141 146
12. S. Kurahara, M. Shinohara, T. Ikebe, S. Nakamura, M. Beppu, and A. Hiraki Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis Head Neck 21 7 1999 627 638
13. C. Ondruschka, P. Buhtz, C. Motsch, B. Freigang, R. Schneider-Stock, and A. Roessner Prognostic value of MMP-2, -9 and TIMP-1, -2 immunoreactive protein at the invasion front in advanced head and neck squamous cell carcinomas Pathol Res Pract 198 8 2002 509 515
14. W.W. Liu, Z.Y. Zeng, Q.L. Wu, J.H. Hou, and Y.Y. Chen Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis Otolaryngol Head Neck Surg 132 3 2005 395 400
15. T. Yoshizaki, Y. Maruyama, H. Sato, and M. Furukawa Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma Int J Cancer 95 1 2001 44 50
16. H. Ruokolainen, P. Pääkkö, and T. Turpeenniemi-Hujanen Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis Clin Cancer Res 10 9 2004 3110 3116
17. H. Ruokolainen, P. Pääkkö, and T. Turpeenniemi-Hujanen Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma-tissue immunoreactivity predicts aggressive clinical course Mod Pathol 19 2 2006 208 217
18. S. Saussez, S. Cludts, A. Capouillez, G. Mortuaire, K. Smetana, and H. Kaltner Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7 Int J Oncol 34 2 2009 433 439
19. A. Katayama, N. Bandoh, K. Kishibe, M. Takahara, T. Ogino, and S. Nonaka Expression of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis Clin Cancer Res 10 2 2004 634 640
20. T. Görögh, U.H. Beier, J. Bäumken, J.E. Meyer, M. Hoffmann, and S. Gottschlich Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas Head Neck 28 1 2006 31 39
21. Y. Imanishi, M. Fujii, Y. Tokumaru, T. Tomita, M. Kanke, and J. Kanzaki Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma Human Pathol 31 8 2000 895 904
22. J.C. De Vicente, M.F. Fresno, L. Villalain, J.A. Vega, and G. Hernández Vallejo Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma Oral Oncol 41 3 2005 283 293
23. J.T. Korpi, V. Kervinen, H. Mäklin, A. Väänänen, M. Lahtinen, and E. Läärä Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer Br J Cancer 98 4 2008 766 775
24. A. Kosunen, R. Pirinen, K. Ropponen, M. Pukkila, J. Kellokoski, and J. Virtaniemi CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma Oral Oncol 43 1 2007 51 59